Gabapentin Tablet, Film Coated
Product Images NDC 82009-072

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82009-072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Creatinine Clearance (Gabapentin Fig1)

Chemical structure diagram illustrating a formula for estimating creatinine clearance (CLCr) based on age, weight, serum creatinine level, and gender adjustment. It is a mathematical expression, not a drug product image.*

FDA Label Image

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (Gabapentin Fig2)

A line chart titled 'Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1' comparing mean pain scores over eight weeks between placebo and gabapentin 3600 mg/day groups. The x-axis represents weeks including baseline, and the y-axis shows mean pain scores from 0 to 10. The chart indicates a decreasing trend in pain scores for gabapentin, while placebo scores remain relatively stable.*

FDA Label Image

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (Gabapentin Fig3)

A line graph titled 'Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2' showing mean pain scores over 7 weeks. It compares three groups: Placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day, with a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis represents mean pain score from 0 to 10; the x-axis represents weeks from baseline to 7.*

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Gabapentin Fig4)

A bar chart showing the proportion of responders with at least 50% reduction in pain score at study endpoint in two controlled PHN studies. The chart compares placebo (PBO) with different doses of gabapentin (GBP) 1800, 2400, and 3600 mg, indicating higher responder rates for gabapentin groups in both studies with statistical significance.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig5)

A scatter plot showing responder rate differences (%) from placebo versus daily dose (mg) of Gabapentin in patients aged 12 years and older with partial seizures. The plot compares results from three studies labeled as Study a, Study b, and Study c, with dose ranges approximately from 600 mg to 1800 mg.*

FDA Label Image

Package Label-principal Display Panel (600 mg (100 Tablets Bottle))

Label for Gabapentin Tablets USP 600 mg oral film-coated tablets, with a 500 tablet count. The label indicates the product is prescription only (Rx only) and includes storage instructions at 20° to 25°C. Manufactured by APL Health Care Limited and for Quallent Pharmaceuticals Health LLC. Barcode and manufacturer details are also visible.*

FDA Label Image

Package Label-principal Display Panel (800 mg (100 Tablets Bottle))

Gabapentin Tablets USP 800 mg film-coated tablets label from Quallent Pharmaceuticals Health LLC, showing a 500 tablet count. The label includes storage instructions (20° to 25°C), manufacturing details from APL Health Care Limited in India, and a bar code. It features a graphic of a tablet and emphasizes pharmacist dispensing of the Medication Guide.*

FDA Label Image

Chemical Structure (Gabapentin Str)

Chemical structure of gabapentin depicted as a cyclohexane ring bonded to an aminomethyl group (CH2NH2) and an acetic acid moiety (CH2CO2H). The image shows the molecular framework relevant to the gabapentin active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.